André C, Stankeviciute L, Michaelian JC, Antonsdottir IM, Benca RM, Coulthard EJ, D'Rozario AL, Dijk DJ, Gimenez S, Gorgoni M, Leng Y, Lucey BP, Pase MP, Rainey-Smith SR, Rosenzweig I, Spira AP, Winer JR, Rauchs G, Naismith SL. International recommendations for sleep and circadian research in aging and Alzheimer's disease: A Delphi consensus study.. ALZHEIMERS & DEMENTIA. 2025; 21(10)DOI:10.1002/alz.70742. PMID:41164883. IF:(Q/D).

Ramos-Rodríguez, J, Bonete-Sánchez, M, Ruiz-Ramos, J, Calderon-Hernanz, B, Campino-Villegas, A, de Lorenzo-Pinto, A, García-Peláez, M, García-Gutiérrez, MD, García-Martin, A, Real-Campaña, JM, Ginés-Palomares, A, Such-Díaz, A, Vallvé-Alcon, E, Alonso-Ramos, H. Impact on safety and cost of pharmaceutical interventions in the emergency department (INTERPHAR): a standardized methodology for multicenter documentation. EMERGENCIAS. 2025; 37(5)DOI:10.55633/s3me/082.2025. PMID:41185476. IF:6.300(Q1/1D).

Bernal-Labrador, E, Romaguera, R, Garcia-Blas, S, Regueiro, A, Serra, V, Asmarats, L, Tizon-Marcos, H, Agudelo, V, Scardino, C, Casanova-Sandoval, JM, Rodríguez-Gabella, T, Jiménez-Méndez, C, Pérez-Rivera, A, Robles-Gamboa, C, Ayesta, A, Díez-Villanueva, P, Raposeiras-Roubín, S, Amat-Santos, IJ, Esteve-Pastor, A, Veiga-Fernández, G, Anguita, M, Martí-Sánchez, D, Martínez-Velilla, N, Cortés, L, Calvo, E, Asimbaya, S, Formiga, F, Ariza-Solé, A. Telematic intervention on frailty in patients undergoing TAVI. Design of the TELE-FRAIL TAVI clinical trial. REC, interventional cardiology. 2025; 7(4)DOI:10.24875/RECIC.M25000522. PMID:41333125. IF:(Q/D).

Romero-Gómez, M, Escalada, J, Noguerol, M, Pérez, A, Carretero, J, Crespo, J, Mascort, JJ, Aguilar, I, Tinahones, F, Canones, P, Gómez-Huelgas, R, de Luis, D, Trullos, IG, Aller, R, Rubio, MA. Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis. Gastroenterologia y Hepatologia. 2025; 48(8)DOI:10.1016/j.gastrohep.2025.502442. PMID:40221023. IF:1.900(Q3/7D).

Ma, CX, Ma, XN, Li, HL, Mauricio, D, Fu, SB. Endocrine-disrupting chemicals exposure: cardiometabolic health risk in humans. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02938-8. PMID:41035032. IF:10.600(Q1/1D).

Grohé, C, Wu, YL, Tsuboi, M, Majem, M, John, T, Bolanos, A, Taylor, R, Sandelin, M, Herbst, RS. Early Treatment Discontinuation of Osimertinib in the Adjuvant Setting: Insights From the ADAURA Study. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).

Ramírez, ERV, de Maeztu, G, de Arizón, LF, Teran, MP, Torra, R. Leveraging AI for early detection of chronic kidney and hereditary kidney diseases: a focus on Alport syndrome. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.1061. PMID:. IF:5.600(Q1/1D).

Provencio, M, Aguiar, D, Antoñanzas, M, Areses, MC, Azkárate, A, Barba, A, Bernabé, R, Blanco, R, Borregon, M, Campos, B, Coves, J, De Castro, J, Domènech, M, Domine, M, Campelo, RG, Gozálvez, CL, Huidobro, G, Insa, A, Juan-Vidal, O, Castro, RL, Martínez-Marti, A, Medina, S, Moreno, MA, Nadal, E, Olivares, A, Reguart, N, Sala, MA, Medina, K, Vilà, L, Massuti, B. ARIAN, Adjuvant Treatment With Sacituzumab and ZimberelimAb in Resected Patients: A Phase III Study-Trial in Progress. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).